These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Chemotherapy of esophageal carcinoma]. Herrmann R Schweiz Med Wochenschr; 1993 May; 123(21):1103-5. PubMed ID: 8511542 [TBL] [Abstract][Full Text] [Related]
26. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study. Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993 [TBL] [Abstract][Full Text] [Related]
27. Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study. Dipetrillo T; Milas L; Evans D; Akerman P; Ng T; Miner T; Cruff D; Chauhan B; Iannitti D; Harrington D; Safran H Am J Clin Oncol; 2006 Aug; 29(4):376-9. PubMed ID: 16891865 [TBL] [Abstract][Full Text] [Related]
28. Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. DuVall GA; Tarabar D; Seidel RH; Elstad NL; Fowers KD Anticancer Drugs; 2009 Feb; 20(2):89-95. PubMed ID: 19209024 [TBL] [Abstract][Full Text] [Related]
29. [A case of stage IV (N4) esophageal cancer successfully treated with concurrent chemoradiotherapy]. Tsuchiyama T; Maeda H; Iida A; Fujita T; Kobayashi T; Katayama SK; Hirose K; Yamaguch A; Nakagawara G Gan To Kagaku Ryoho; 1998 Oct; 25(12):1965-8. PubMed ID: 9797821 [TBL] [Abstract][Full Text] [Related]
30. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer. Nakamura T; Ota M; Hayashi K; Eguchi R; Ide H; Takasaki K; Mitsuhashi N Hepatogastroenterology; 2006; 53(71):705-9. PubMed ID: 17086873 [TBL] [Abstract][Full Text] [Related]
31. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460 [TBL] [Abstract][Full Text] [Related]
32. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula. Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437 [TBL] [Abstract][Full Text] [Related]
33. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification. Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517 [TBL] [Abstract][Full Text] [Related]
34. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer]. Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020 [TBL] [Abstract][Full Text] [Related]
35. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S; Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565 [TBL] [Abstract][Full Text] [Related]
36. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001. Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863 [TBL] [Abstract][Full Text] [Related]
37. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928 [TBL] [Abstract][Full Text] [Related]
38. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma. Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206 [TBL] [Abstract][Full Text] [Related]
39. Esophageal cancer: adjuvant therapy. Ku GY; Ilson DH Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765 [TBL] [Abstract][Full Text] [Related]
40. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]